Bollard Group’s Veracyte VCYT Stock Holding History

Bollard Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,850	Closed	-$51K	–	414
2022 Q1	$51K	Hold	1,850	–	–	﹤0.01%	341
2021 Q4	$76K	Hold	1,850	–	–	﹤0.01%	313
2021 Q3	$86K	Hold	1,850	–	–	﹤0.01%	297
2021 Q2	$74K	Hold	1,850	–	–	﹤0.01%	315
2021 Q1	$99K	Hold	1,850	–	–	﹤0.01%	279
2020 Q4	$91K	Hold	1,850	–	–	﹤0.01%	282
2020 Q3	$60K	Hold	1,850	–	–	﹤0.01%	312
2020 Q2	$48K	Buy	+1,850	New	+$46.1K	﹤0.01%	347

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bollard Group's VCYT Position: Q2 2022 in Review

Bollard Group sold out of Veracyte (VCYT) in Q2 2022, closing a stake of 1,850 shares — an estimated $51K sold.

Bollard Group first reported a position in VCYT in Q2 2020 and held it in 8 quarters. The position peaked at $99K in Q1 2021. 193 funds tracked by Wall St. Rank hold VCYT as of Q2 2022.

Bollard Group reported no remaining Veracyte position as of Q2 2022 after selling out during the quarter.
Bollard Group sold 1,850 Veracyte shares in Q2 2022, an estimated $51K.
Bollard Group first reported a position in Veracyte in Q2 2020 and held it in 8 quarters.
Bollard Group's Veracyte position peaked at $99K in Q1 2021.
193 funds tracked by Wall St. Rank held Veracyte as of Q2 2022.

Based on Bollard Group's 13F filing for Q2 2022, filed 12 Aug 2022.